Carien Leandri Van der Berg

Carien Leandri Van der Berg

Auto-generated profile, based on publicly available information

Carien Leandri Van der Berg

Human Metabolomics, North-West University (Potchefstroom Campus), Potchefstroom, 2531, South Africa

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Analytical Biochemistry
Verified
Journal Article
Closed access
CBCarien van der Berg
Carien van der Berg
GVGerda Venter
Gerda Venter
FWFrancois H. van der Westhuizen
Francois H. van der Westhuizen
EEElardus Erasmus
Elardus Erasmus

GVGerda Venter
Gerda Venter
CBCarien L. van der Berg
Carien L. van der Berg
FWFrancois H. van der Westhuizen
Francois H. van der Westhuizen
EEElardus Erasmus
Elardus Erasmus
Combined oral contraceptive (COC) use has been associated with various adverse effects. Formulations containing drospirenone (DRSP) and ethinyl estradiol (EE) are generally regarded as milder COCs. Whether long term use of these pills indeed has a low health risk remains questionable. COC use may affect the biotransformation balance by increasing the toxic load or by interfering with the pharmacokinetics of other drugs. This may negatively impact overall health via the production of toxic biotransformation metabolites and induction of oxidative stress. Although individual enzymes involved in biotransformation are known to be regulated by COCs, the effect of COC use on the overall liver biotransformation efficiency has not been reported. Here, we evaluated the general subjective health status and overall liver biotransformation efficiency of healthy young women who were either long term chronic users of COCs containing DRSP/EE, or who were not using any hormonal products. COC users suffered from moderate to severe fatigue and reported more health-related symptoms. Furthermore, phase I (CYP1A2) activity was reduced whereas phase II conjugation reactions (glucuronide conjugation and glycine conjugation) were increased in COC users. Finally, serum peroxide levels were markedly elevated and antioxidant capacity of plasma was reduced in COC users. COCs containing DRSP/EE may, therefore, adversely affect health status and disturb the balance between phase I and II biotransformation reactions. These effects may be mediated by oxidative stress.

1 April 2020 in Data in Brief
Verified
Journal Article
Open access
CBCarien L. van der Berg
Carien L. van der Berg
GVGerda Venter
Gerda Venter
FWFrancois H. van der Westhuizen
Francois H. van der Westhuizen
EEElardus Erasmus
Elardus Erasmus
Certain estrogen metabolites have been implicated in the pathophysiology of breast cancer. Moreover, the estrogen metabolite profiles of healthy women and those with (a high risk of) breast cancer differ significantly. The development of an analytical method to determine the relative levels of all the estrogen biotransformation products has been described in van der Berg et al. [1]. An improvement on previously developed methods was the ability to also detect molecules such as sulphate and glucuronide conjugates as well as progesterone, estradiol precursors, and metabolites from the 16-hydroxylation metabolic pathway of estrogens simultaneously with all other estrogen metabolites. The data presented here describe the optimisation of a solid phase extraction method with different fractionation steps for LC-MS/MS analysis of 27 estrogen-related metabolites from small urine volumes. Conditions that were optimised include the elution and washing solvent concentration, the urine, loading, washing, and elution volumes, as well as pH. All raw data used to construct the bar graphs presented in this article are included in the supplementary data file. The data indicated that fractionation was necessary in order to elute estrogen metabolites with different chemical properties at different eluate compositions. Only one of the fractions (containing the less water-soluble metabolites) underwent derivatisation before LC-MS/MS analysis.

13 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
HPHeidi N. du Preez
Heidi N. du Preez
SBSooraj Baijnath
Sooraj Baijnath
CBCarien Leandri Van der Berg
Carien Leandri Van der Berg
EEElardus Erasmus
Elardus Erasmus
IPIlse Du Preez
Ilse Du Preez
HKHendrick G. Kruger
Hendrick G. Kruger
Sulfur metabolism is a critical yet underexplored regulator of redox balance, inflammatory signaling, and methylation capacity. Methylsulfonylmethane (MSM) has been proposed to influence these pathways, but its metabolic effects remain poorly defined relative to classical antioxidants. In this study, MSM was compared with N-acetylcysteine (NAC) and vitamin C in a rat model of lipopolysaccharide-induced inflammatory stress, integrating targeted sulfur and one-carbon metabolomics with oxidative, inflammatory, endothelial, and mitochondrial biomarkers.At 18 h post-challenge, MSM produced a distinct sulfur-flux signature characterized by reduced cysteine-S-sulfate and homocysteine without accumulation of oxidized sulfur derivatives, decreased S-adenosylhomocysteine, and an increased S-adenosylmethionine/S-adenosylhomocysteine ratio, consistent with attenuation of sulfite stress and stabilization of methylation balance. In contrast, NAC and vitamin C modulated cysteine and S-adenosylmethionine, but were associated with higher oxidized sulfur species, reflecting direct thiol and electron-donor buffering. Systemic inorganic sulfate levels remained unchanged across groups, indicating tight whole-body regulation; however, MSM-specific upstream shifts suggest enhanced capacity for tissue-level sulfation.Classical markers of endothelial activation and glycocalyx shedding did not differ between groups, likely reflecting the timing of sampling relative to acute shedding kinetics. All interventions reduced urinary free carnitine, consistent with preserved mitochondrial β-oxidation. MSM was associated with modest, coordinated, non-suppressive cytokine changes indicative of adaptive immunomodulation.Collectively, these findings identify MSM as a sulfation-directed metabolic regulator that stabilizes sulfur and methylation pathways under inflammatory stress, distinguishing it mechanistically from conventional antioxidants and expanding redox biology to include sulfur trafficking and sulfation-dependent regulation with relevance to inflammatory and barrier-related disease processes.

26 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GVGerda Venter
Gerda Venter
CBCarien L. van der Berg
Carien L. van der Berg
TJTarien Jacobs
Tarien Jacobs
FWFrancois H. van der Westhuizen
Francois H. van der Westhuizen
EEElardus Erasmus
Elardus Erasmus
Combined oral contraceptives (COCs) are commonly prescribed for the prevention of pregnancy, as well as numerous other non-contraceptive health reasons. COCs act by suppressing the natural hormonal fluctuations of the menstrual cycle that result in ovulation. No studies have investigated the effects of COC use on endogenous estrogen biotransformation and the production of estrogen metabolites. This is important since imbalances in hormone biotransformation (e.g., inefficient methylation by catechol O-methyltransferases; COMT) are implicated in the initiation of breast cancer through the generation of genotoxic metabolites (i.e., estrogen quinones) and reactive oxygen species (ROS), and the depletion of vital antioxidants and metabolic cofactors. Here, we quantified the urinary levels of various estrogen precursors and metabolites in healthy young women who were using COCs containing drospirenone (DRSP) and ethinyl estradiol (EE) (n = 24) and controls (n = 25) via liquid chromatography–tandem mass spectrometry (LC‒MS/MS). In addition, we analysed several circulatory intermediates of the methylation cycle that are linked to the methylation of catechol estrogens via LC‒MS/MS. We found that free urinary estradiol (E2) and estrone (E1) were significantly lower, while 2-methoxyestrone (2-MeOE1) levels were significantly higher in COC users. Excretion of some metabolites including 16-hydroxylation pathway metabolites, glutathione conjugates, and DNA-adducts were also lower in COC users, although total hormone and metabolite excretion levels were not significantly different. Estrone metabolite ratios were higher in COC users, including 2&4-MeOE1:E1, 2&4-OHE1:E1, E1-3-sulphate: E1, and E1-3-glucuronide: E1. There was a positive correlation between 2-hydroxyestrogen and 2-methoxyestrogen levels in controls but not in COC users. In addition, the serum betaine and dimethylglycine (DMG) levels, as well as the betaine: choline ratio, were reduced in COC users, whereas the levels of choline and serine and the DMG: betaine ratio were significantly increased. DMG levels positively correlated with methoxyestrogens and methoxyestrogen: hydroxyestrogen ratios in COC users, while S-adenosylmethionine (SAM) negatively correlated with 2-MeOE2. Our data suggests that the use of EE/DRSP increases the flux of endogenous hormones into the hormone biotransformation pathway, resulting in increased conversion of estrogens (especially E1) into conjugated, catechol, and methylated estrogens but that the latter is limited by methyl-group donor availability. Interestingly, the increased oxidation of estrogens in COC users does not result in increased DNA-adduct formation.